Tara Aghaloo, DDS
Oral & Maxillofacial Surgery · Los Angeles, CANPI 1740464692
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Dentsply IH Inc. at 38.5% of the total. Reporting peaked in 2023 at $86,611 and has fallen 80.4% since, to $16,969 in 2025. Among oral & maxillofacial surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $835.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dentsply IH Inc.$82K
- Dentsply Sirona Inc$45K
- Geistlich Pharma, North America, Inc.$17K
- Keystone Dental Inc.$16K
- AbbVie$14K
- MIS Implants Technologies, Inc.$12K
- plus $27K from 7 others
Across 11 payments — averaging $15,472 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Radius Health, Inc.$97K
- Straumann USA LLC$73K
What the payments were for
- Consulting fees$32,15215%
- Speaking & faculty fees$118,76256%
- Travel & lodging$48,15923%
- Food & beverage$12,4826%
- Education$9280%
- Gifts$6000%
- Entertainment$8150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dentsply IH Inc. | 55 | $82,244 |
| Dentsply Sirona Inc | 68 | $44,837 |
| Geistlich Pharma, North America, Inc. | 25 | $16,767 |
| Keystone Dental Inc. | 7 | $16,342 |
| AbbVie | 6 | $14,459 |
| MIS Implants Technologies, Inc. | 3 | $12,247 |
| Biohorizons Implant Systems Inc. | 50 | $9,063 |
| Hiossen, Inc. | 1 | $5,935 |
| Straumann USA LLC | 13 | $5,471 |
| Nobel Biocare USA | 2 | $2,514 |
| Stryker | 19 | $2,199 |
| Kls-martin L.p. | 2 | $1,411 |
| Axogen | 5 | $407 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Implant Dentistry$110,810
- BIOHORIZONS$36,165
- BOTOX$14,438
- Bio-Oss$6,256
- Geistlich Bio Gide$3,572
- NA$2,875
- NO PRODUCT$2,565
- NOBELPARALLEL$2,500
- NOBELACTIVE$2,500
- Fibro-Gide$2,000
- SMARTLOCK$1,167
- SYMBIOS$413
- Bio-Materials$277
- AVANCE NERVE GRAFT$244
- CEREC$186
- Bio-Gide$185
- BioHorizons Dental Implants$121
- ASTRA TECH Implant System$119
How this compares
$213,897 in reported general payments places this provider in the 95th percentile of 941 oral & maxillofacial surgery providers in California.
See all oral & maxillofacial surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 252 | $2,001 |
| Chlorhexidine Gluconate | 143 | $786 |
| Metronidazole | 18 | $404 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $206 |
| Ibuprofen | 45 | $172 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $137 |
| Azithromycin | 11 | $132 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $31 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Los Angeles
- Peter MoyLos Angeles$175K
- Michael BaeLos Angeles$22K
- Gil IvryLos Angeles$18K
- Wayne OzakiLos Angeles$12K
- Alexander McMahonLos Angeles$10K
- Edmond BedrossianSan Francisco$3.7M
- Peter WohrleNewport Beach$735K
- Jone KimBrea$721K
- G William ArnettSanta Barbara$713K
- Arshiya SharafiSan Diego$457K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.